WVE - Wave Life Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.38
DETAILS
HIGH:
$43.00
LOW:
$13.00
MEDIAN:
$28.00
CONSENSUS:
$26.38
UPSIDE:
313.48%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Druckenmiller | 173,000 | $1.3M | 0.0% | -- | UNCHANGED |
| Cooperman | 72,305 | $524,211 | 0.0% | -193,827 | DECREASED |
| Wood | 36,600 | $265,350 | 0.0% | +36,600 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | 350,000 | $5.85 | $2.0M |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | 200,000 | $11.74 | $2.3M |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | 273,750 | $12.75 | $3.5M |
| 2026-04-09 | Wright Christopher I | officer: Chief Medical Officer | ? | -- | -- | -- |
| 2026-04-09 | Wright Christopher I | officer: Chief Medical Officer | ? | 300,000 | $5.94 | $1.8M |
| 2026-04-09 | Wright Christopher I | officer: Chief Medical Officer | ? | 273,750 | $12.75 | $3.5M |
| 2026-04-09 | Ingelsson Erik | officer: Chief Scientific Officer | ? | -- | -- | -- |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 2,495,623 | $6.43 | $16.0M |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 4,954,558 | $6.06 | $30.0M |
| 2026-03-26 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 351,224 | $6.38 | $2.2M |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | BUY | 971,091 | $6.50 | $6.3M |
| 2026-03-23 | TAKANASHI KEN | director | C-Conversion | 3,901,348 | -- | -- |
| 2026-02-26 | Francis Chris | officer: See Remarks | M-Exempt | 17,900 | $3.87 | $69K |
| 2026-02-26 | Francis Chris | officer: See Remarks | SELL | 17,900 | $15.09 | $270K |
| 2026-02-26 | Francis Chris | officer: See Remarks | SELL | 15,294 | $15.00 | $229K |
| 2026-02-26 | Francis Chris | officer: See Remarks | M-Exempt | 15,294 | $4.75 | $73K |
| 2026-02-05 | BOLNO PAUL | director, officer: President and CEO | A-Award | 1,000,000 | $12.75 | $12.8M |
| 2026-02-09 | BOLNO PAUL | director, officer: President and CEO | SELL | 10,480 | $13.45 | $141K |
| 2026-02-09 | Vargeese Chandra | officer: See Remarks | SELL | 3,228 | $13.45 | $43K |
| 2026-02-05 | Vargeese Chandra | officer: See Remarks | A-Award | 273,750 | $12.75 | $3.5M |
| 2026-02-09 | Moran Kyle | officer: Chief Financial Officer | SELL | 3,588 | $13.45 | $48K |
| 2026-02-05 | Vargeese Chandra | officer: See Remarks | A-Award | 45,625 | -- | -- |
| 2026-02-05 | BOLNO PAUL | director, officer: President and CEO | A-Award | 165,000 | -- | -- |
| 2026-02-09 | Francis Chris | officer: See Remarks | SELL | 1,883 | $13.45 | $25K |
| 2026-02-05 | Francis Chris | officer: See Remarks | A-Award | 232,500 | $12.75 | $3.0M |